TREMIN Drug Patent Profile
Which patents cover Tremin, and what generic alternatives are available?
Tremin is a drug marketed by Schering and is included in one NDA.
The generic ingredient in TREMIN is trihexyphenidyl hydrochloride. There is one drug master file entry for this compound. Eight suppliers are listed for this compound. Additional details are available on the trihexyphenidyl hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tremin
A generic version of TREMIN was approved as trihexyphenidyl hydrochloride by WATSON LABS on December 31st, 1969.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TREMIN?
- What are the global sales for TREMIN?
- What is Average Wholesale Price for TREMIN?
Summary for TREMIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 99 |
| Patent Applications: | 3,327 |
| DailyMed Link: | TREMIN at DailyMed |
US Patents and Regulatory Information for TREMIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | TREMIN | trihexyphenidyl hydrochloride | TABLET;ORAL | 080381-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Schering | TREMIN | trihexyphenidyl hydrochloride | TABLET;ORAL | 080381-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
